Purchase / NY. (pci) PepsiCo Inc. announced the election of Dr. David C. Page to its Board of Directors. Page will join the Board effective November 20, 2014. Page, 58, brings 30 years of experience in science and medicine to PepsiCo. He currently serves as the director of the Whitehead Institute for Biomedical Research, an independent non-profit research and educational institution affiliated with Massachusetts Institute of Technology (MIT). He leads a group of scientists focused on cancer research, immunology, developmental biology, stem cell research, regenerative medicine, genetics and genomics. Page also serves as a professor of biology at MIT and as an investigator at the Howard Hughes Medical Institute. «I am pleased to welcome David to the PepsiCo Board of Directors», said PepsiCo Chairman and CEO Indra Nooyi. «David is a highly respected leader in the scientific community whose research has consistently produced significant discoveries and breakthroughs. His expertise will be a valuable addition to the PepsiCo Board as we continue to execute our strategy for delivering sustainable long-term growth». Ray Hunt, chair of the PepsiCo Nominating and Corporate Governance Committee and chairman and CEO of Hunt Consolidated, said: «David is a distinguished leader and thinker who is widely regarded as one of the foremost experts in his field. He will bring unique perspectives to the PepsiCo Board that help to maximize future growth opportunities and shareholder value creation».